Company / Shares Outstanding
CRESCENT BIOPHARMA, INC. Shares Outstanding History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.0M
FY2025
5-year range
1.0M / 23.3M
FY2021-FY2025
Trend
-95.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 19050204.00 to 1018604.00 over the past 9 years.
Based on SEC 10-K filings.
1018604.00 in FY2025 with a 10-year CAGR of -25.3%.
Improved from 19050204.00 to 1018604.00 over the past 9 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -25.3%
Key checks
Key Insights
- In FY2025, shares outstanding decreased 95.6% year-over-year.
- Peak shares outstanding was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.0M | -95.6% |
| FY2017 | 23.3M | +22.0% |
| FY2016 | 19.1M | +0.6% |
| FY2015 | 18.9M | +1227.6% |
| FY2014 | 1.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026